CompletedNCT07780617SAPS II SOFAUpdated Aug 21, 2026

Comparison of Simplified Acute Physiology Score (SAPS II) , Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation) APACHE II Scoring Systems for Predicting Mortality of Critically Ill Patients Admitted in a Tertiary Hospital Intensive Care Unit.

An observational study in ICU Mortality, sponsored by Tribhuvan University Teaching Hospital, Institute Of Medicine.. Completed at 1 site in Nepal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.

Sponsored by Tribhuvan University Teaching Hospital, Institute Of Medicine. · Observational

Study type: Observational
Model: Other
Time perspective: Prospective
Enrollment: 201
Ages: 18 Years and older
Sex: All

Study summary

This is a descriptive analytical prospective study to compare the performance of SOFA score, SAPSII score and APACHE II score in ICU mortality prediction.

Read the detailed description

All the eligible patients admitted to the ICU are enrolled in the study. For each enrolled patient SAPS II, SOFA and APACHE II score will be calculated and these patient will be followed till they are in ICU stay. A comparison of predictive performance of each score will be done for mortality in the ICU.

Conditions studied

ICU Mortality

In context

Lead sponsor

Tribhuvan University Teaching Hospital, Institute Of Medicine. is the lead sponsor of 41 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: No
Sampling method: Non-probability sample

Study population

Admitted to ICU

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

18 years and above Admitted to ICU with expected stay of more or equal to 24 hours

Exclusion criteria

Exclusion Criteria:

whose consent could not be obtained
treatment limitation order in form of DNI/DNR, withdrawal of life support

Study design

Observational model: Other
Time perspective: Prospective
Enrollment: 201 participants (actual)
Target follow-up: 1 Month
Patient registry: Yes

What researchers measure

Primary outcomes

mortality
ICU mortality
Time frame: Through study period on average 1 year

Study locations

1 site

Bharatpur Hospital
Bharatpur, Bagmati, Nepal

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reached

Ran from Jul 2025 to primary completion in Dec 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered: Aug 12, 2026
First posted: Aug 21, 2026
StartActual: Jul 1, 2025
Primary completionActual: Dec 30, 2025
CompletionActual: Jan 30, 2026
Last update: Aug 21, 2026

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Aug 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT07780617
Lead sponsor: Tribhuvan University Teaching Hospital, Institute Of Medicine.
Responsible party: Ashmita Paudel (Principal Investigator, College of Medical Sciences Teaching Hospital. Nepal) — Principal investigator
First posted: Aug 21, 2026
Start date: Jul 1, 2025
Primary completion: Dec 30, 2025
Completion: Jan 30, 2026
Last update: Aug 21, 2026

Study contacts

Ashmita Paudel

principal investigator · Bharatpur Eye Hospital

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Start the discussion